AP-1/c-Jun transcription factors: Regulation and function in malignant melanoma

European Journal of Cell Biology

Volumn 93, Issue 1-2, 2014, Pages 76-81

  Kappelmann, Melanie ^a   Bosserhoff, Anja ^a   Kuphal, Silke ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

AP 1; C Jun; Cytoskeleton; Melanoma; MiR; Post transcriptional regulation

Indexed keywords

MICRORNA 125B; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; UVOMORULIN; CADHERIN; MICRORNA; MIRN125 MICRORNA, HUMAN; STRESS ACTIVATED PROTEIN KINASE;

CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE MUTATION; HUMAN; KERATINOCYTE; MELANOCYTE; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SHORT SURVEY; SOLID TUMOR; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; GENETICS; METABOLISM; SIGNAL TRANSDUCTION; SKIN TUMOR;

CADHERINS; CARCINOGENESIS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MELANOMA; MICRORNAS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TRANSCRIPTION FACTOR AP-1;

EID: 84897523802     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2013.10.003     Document Type: Short Survey

References (92)

1. Agarwal S.K., Guru S.C., Heppner C., Erdos M.R., Collins R.M., Park S.Y., Saggar S., Chandrasekharappa S.C., Collins F.S., Spiegel A.M., Marx S.J., Burns A.L. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 1999, 96:143-152.
2. Angel P., Imagawa M., Chiu R., Stein B., Imbra R.J., Rahmsdorf H.J., Jonat C., Herrlich P., Karin M. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 1987, 19(49):729-739.
3. Angel P., Szabowski A., Schorpp-Kistner M. Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene 2001, 20:2413-2423.
4. Bakiri L., Lallemand D., Bossy-Wetzel E., Yaniv M. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J. 2000, 19:2056-2068.
5. Bakiri L., Matsuo K., Wisniewska M., Wagner E.F., Yaniv M. Promoter specificity and biological activity of tethered AP-1 dimers. Mol. Cell. Biol. 2002, 22:4952-4964.
6. Ball N.J., Yohn J.J., Morelli J.G., Norris D.A., Golitz L.E., Hoeffler J.P. Ras mutations in human melanoma: a marker of malignant progression. J. Invest. Dermatol. 1994, 102:285-290.
7. Bennett G.D., Lau F., Calvin J.A., Finnell R.H. Phenytoin-induced teratogenesis: a molecular basis for the observed developmental delay during neurulation. Epilepsia 1997, 38:415-423.
8. Bhoumik A., Ronai Z. ATF2: a transcription factor that elicits oncogenic or tumor suppressor activities. Cell Cycle 2008, 7:2341-2345.
9. Blau L., Knirsh R., Ben Dror I., Oren S., Kuphal S., Hau P., Proescholdt M., Bosserhoff A.K., Vardimon L. Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation. Proc. Natl. Acad. Sci. U.S.A 2012, 109:E2875-E2884.
10. Bohmann D., Bos T.J., Admon A., Nishimura T., Vogt P.K., Tjian R. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 1987, 238:1386-1392.
11. Bos T.J., Margiotta P., Bush L., Wasilenko W. Enhanced cell motility and invasion of chicken embryo fibroblasts in response to Jun over-expression. Int. J. Cancer 1999, 81:404-410.
12. Bossis G., Malnou C.E., Farras R., Andermarcher E., Hipskind R., Rodriguez M., Schmidt D., Muller S., Jariel-Encontre I., Piechaczyk M. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol. Cell. Biol. 2005, 25:6964-6979.
13. Brenner D.A., O'Hara M., Angel P., Chojkier M., Karin M. Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature 1989, 337:661-663.
14. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:2999-3004.
15. Cavalieri F., Ruscio T., Tinoco R., Benedict S., Davis C., Vogt P.K. Isolation of three new avian sarcoma viruses: ASV 9, ASV 17, and ASV 25. Virology 1985, 143:680-683.
16. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M.J., Bottomley W., Davis N., Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J., Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S., Hooper S., Wilson R., Jayatilake H., Gusterson B.A., Cooper C., Shipley J., Hargrave D., Pritchard-Jones K., Maitland N., Chenevix-Trench G., Riggins G.J., Bigner D.D., Palmieri G., Cossu A., Flanagan A., Nicholson A., Ho J.W., Leung S.Y., Yuen S.T., Weber B.L., Seigler H.F., Darrow T.L., Paterson H., Marais R., Marshall C.J., Wooster R., Stratton M.R., Futreal P.A. Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954.
17. de Souza C.F., Morais A.S., Jasiulionis M.G. Biomarkers as key contributors in treating malignant melanoma metastases. Dermatol. Res. Pract. 2012, 2012:156068. (Epub; 2011, October 31, 156068). 10.1155/2012/156068.
18. Deng Y., Deng H., Bi F., Liu J., Bemis L.T., Norris D., Wang X.J., Zhang Q. MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines. Int. J. Biol. Sci. 2011, 7:133-137.
19. Devary Y., Gottlieb R.A., Lau L.F., Karin M. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell. Biol. 1991, 11:2804-2811.
20. Devary Y., Gottlieb R.A., Smeal T., Karin M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 1992, 71:1081-1091.
21. Eferl R., Ricci R., Kenner L., Zenz R., David J.P., Rath M., Wagner E.F. Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 2003, 112:181-192.
22. Eferl R., Wagner E.F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 2003, 3:859-868.
23. El Andaloussi S., Johansson H., Magnusdottir A., Jarver P., Lundberg P., Langel U. TP10, a delivery vector for decoy oligonucleotides targeting the Myc protein. J. Control. Release 2005, 110:189-201.
24. Fang Y., Xue J.L., Shen Q., Chen J., Tian L. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology 2012, 55:1852-1862.
25. Fialka I., Schwarz H., Reichmann E., Oft M., Busslinger M., Beug H. The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions. J. Cell. Biol. 1996, 132:1115-1132.
26. Florin L., Hummerich L., Dittrich B.T., Kokocinski F., Wrobel G., Gack S., Schorpp-Kistner M., Werner S., Hahn M., Lichter P., Szabowski A., Angel P. Identification of novel AP-1 target genes in fibroblasts regulated during cutaneous wound healing. Oncogene 2004, 23:7005-7017.
27. Fuchs S.Y., Dolan L., Davis R.J., Ronai Z. Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene 1996, 13:1531-1535.
28. Gebauer F., Hentze M.W. Molecular mechanisms of translational control. Nat. Rev. Mol. Cell. Biol. 2004, 5:827-835.
29. Glud M., Manfe V., Biskup E., Holst L., Dirksen A.M., Hastrup N., Nielsen F.C., Drzewiecki K.T., Gniadecki R. MicroRNA miR-125b induces senescence in human melanoma cells. Melanoma Res. 2011, 21:253-256.
30. Guldberg P., Kirkin A.F., Gronbaek K., Thor S.P., Ahrenkiel V., Zeuthen J. Complete scanning of the CDK4 gene by denaturing gradient gel electrophoresis: a novel missense mutation but low overall frequency of mutations in sporadic metastatic malignant melanoma. Int. J. Cancer 1997, 72:780-783.
31. Gupta S., Campbell D., Derijard B., Davis R.J. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 1995, 20(267):389-393.
32. Herschman H.R. Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem. 1991, 60:281-319. 281-319.
33. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 1993, 7:2135-2148.
34. Hilberg F., Aguzzi A., Howells N., Wagner E.F. c-jun is essential for normal mouse development and hepatogenesis. Nature 1993, 365:179-181.
35. Howell P.M., Li X., Riker A.I., Xi Y. Micro RNA in Melanoma. Ochsner J. 2010, 10:83-92.
36. Jemal A., Saraiya M., Patel P., Cherala S.S., Barnholtz-Sloan J., Kim J., Wiggins C.L., Wingo P.A. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J. Am. Acad. Dermatol. 2011, 65:S17-S25.
37. Jin X., Song X., Li L., Wang Z., Tao Y., Deng L., Tang M., Yi W., Cao Y. Blockade of AP-1 activity by dominant-negative TAM67 can abrogate the oncogenic phenotype in latent membrane protein 1-positive human nasopharyngeal carcinoma. Mol. Carcinog. 2007, 46:901-911.
38. Jochum W., Passegue E., Wagner E.F. AP-1 in mouse development and tumorigenesis. Oncogene 2001, 20:2401-2412.
39. Johannessen C.M., Boehm J.S., Kim S.Y., Thomas S.R., Wardwell L., Johnson L.A., Emery C.M., Stransky N., Cogdill A.P., Barretina J., Caponigro G., Hieronymus H., Murray R.R., Salehi-Ashtiani K., Hill D.E., Vidal M., Zhao J.J., Yang X., Alkan O., Kim S., Harris J.L., Wilson C.J., Myer V.E., Finan P.M., Root D.E., Roberts T.M., Golub T., Flaherty K.T., Dummer R., Weber B.L., Sellers W.R., Schlegel R., Wargo J.A., Hahn W.C., Garraway L.A. COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature 2010, 468:968-972.
40. Kappelmann M., Kuphal S., Meister G., Vardimon L., Bosserhoff A.K. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression. Oncogene 2013, 32:2984-2991.
41. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 1995, 270:16483-16486.
42. Knirsh R., Ben Dror I., Spangler B., Matthews G.D., Kuphal S., Bosserhoff A.K., Vardimon L. Loss of E-cadherin-mediated cell-cell contacts activates a novel mechanism for up-regulation of the proto-oncogene c-Jun. Mol. Biol. Cell. 2009, 20:2121-2129.
43. Kolbus A., Herr I., Schreiber M., Debatin K.M., Wagner E.F., Angel P. c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents. Mol. Cell. Biol. 2000, 20:575-582.
44. Kovary K., Bravo R. The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 1991, 11:4466-4472.
45. Kuphal S., Poser I., Jobin C., Hellerbrand C., Bosserhoff A.K. Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. Oncogene 2004, 23:8509-8519.
46. Lamb R.F., Hennigan R.F., Turnbull K., Katsanakis K.D., MacKenzie E.D., Birnie G.D., Ozanne B.W. AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44. Mol. Cell. Biol. 1997, 17:963-976.
47. Langer S., Singer C.F., Hudelist G., Dampier B., Kaserer K., Vinatzer U., Pehamberger H., Zielinski C., Kubista E., Schreibner M. and Fos family protein expression in human breast cancer: correlation of protein expression and clinicopathological parameters. Eur. J. Gynaecol. Oncol. 2006 Jun, 27:345-352.
48. Le X.F., Merchant O., Bast R.C., Calin G.A. The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade. Cancer Microenviron. 2010, 3:137-147.
49. Li G., Gustafson-Brown C., Hanks S.K., Nason K., Arbeit J.M., Pogliano K., Wisdom R.M., Johnson R.S. c-Jun is essential for organization of the epidermal leading edge. Dev. Cell 2003, 4:865-877.
50. Lopez-Bergami P., Huang C., Goydos J.S., Yip D., Bar-Eli M., Herlyn M., Smalley K.S., Mahale A., Eroshkin A., Aaronson S., Ronai Z. Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 2007, 11:447-460.
51. Maki Y., Bos T.J., Davis C., Starbuck M., Vogt P.K. Avian sarcoma virus 17 carries the jun oncogene. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:2848-2852.
52. Mariani O., Brennetot C., Coindre J.M., Gruel N., Ganem C., Delattre O., Stern M.H., Aurias A. JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas. Cancer Cell 2007, 11:361-374.
53. Mathas S., Hinz M., Anagnostopoulos I., Krappmann D., Lietz A., Jundt F., Bommert K., Mechta-Grigoriou F., Stein H., Dorken B., Scheidereit C. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. EMBO J. 2002, 21:4104-4113.
54. Meister G., Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature 2004, 431:343-349.
55. Mils V., Piette J., Barette C., Veyrune J., Tesniere A., Escot C., Guilhou J.J., Basset-Seguin N. The proto-oncogene c-fos increases the sensitivity of keratinocytes to apoptosis. Oncogene 1997, 14:1555-1561.
56. Morton S., Davis R.J., McLaren A., Cohen P. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J. 2003, 22:3876-3886.
57. Mueller D.W., Bosserhoff A.K. Role of miRNAs in the progression of malignant melanoma. Br. J. Cancer 2009, 101:551-556.
58. Muller S., Berger M., Lehembre F., Seeler J.S., Haupt Y., Dejean A. c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 2000, 275:13321-13329.
59. Nakabeppu Y., Ryder K., Nathans D. DNA binding activities of three murine Jun proteins: stimulation by Fos. Cell 1988, 55:907-915.
60. Omholt K., Platz A., Kanter L., Ringborg U., Hansson J. NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. Clin. Cancer Res. 2003, 9:6483-6488.
61. Papaconstantinou I., Karakatsanis A., Gazouli M., Polymeneas G., Voros D. The role of micro RNAs in liver cancer. Eur. J. Gastroenterol. Hepatol. 2012, 24:223-228.
62. Podar K., Raab M.S., Tonon G., Sattler M., Barila D., Zhang J., Tai Y.T., Yasui H., Raje N., DePinho R.A., Hideshima T., Chauhan D., Anderson K.C. Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myeloma. Cancer Res. 2007, 67:1680-1688.
63. Polak P., Oren A., Ben Dror I., Steinberg D., Sapoznik S., Arditi-Duvdevany A., Vardimon L. The cytoskeletal network controls c-Jun translation in a UTR-dependent manner. Oncogene 2006, 25:665-676.
64. Rangatia J., Vangala R.K., Singh S.M., Peer Zada A.A., Elsasser A., Kohlmann A., Haferlach T., Tenen D.G., Hiddemann W., Behre G. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction. Oncogene 2003, 22:4760-4764.
65. Russo A.E., Torrisi E., Bevelacqua Y., Perrotta R., Libra M., McCubrey J.A., Spandidos D.A., Stivala F., Malaponte G. Melanoma: molecular pathogenesis and emerging target therapies. Int. J. Oncol. 2009, 34:1481-1489. (Review).
66. Schreiber M., Kolbus A., Piu F., Szabowski A., Mohle-Steinlein U., Tian J., Karin M., Angel P., Wagner E.F. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 1999, 13:607-619.
67. Shah M., Bhoumik A., Goel V., Dewing A., Breitwieser W., Kluger H., Krajewski S., Krajewska M., Dehart J., Lau E., Kallenberg D.M., Jeong H., Eroshkin A., Bennett D.C., Chin L., Bosenberg M., Jones N., Ronai Z.A. A role for ATF2 in regulating MITF and melanoma development. PLoS Genet. 2010, 6:e1001258.
68. Shaulian E. AP-1 - the Jun proteins: Oncogenes or tumor suppressors in disguise?. Cell Signal. 2010, 22:894-899.
69. Shaulian E., Karin M. AP-1 in cell proliferation and survival. Oncogene 2001, 20:2390-2400.
70. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat. Cell. Biol. 2002, 4:E131-E136.
71. Shaulian E., Schreiber M., Piu F., Beeche M., Wagner E.F., Karin M. The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell 2000, 103:897-907.
72. Shoo B.A., Kashani-Sabet M. Melanoma arising in African-, Asian-, Latino- and Native-American populations. Semin. Cutan. Med. Surg. 2009, 28:96-102.
73. Smalley K.S. A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?. Int. J. Cancer. 2003, 104:527-532.
74. Somasundaram R., Villanueva J., Herlyn M. Intratumoral heterogeneity as a therapy resistance mechanism: role of melanoma subpopulations. Adv. Pharmacol. 2012, 65:335-359. doi: 10.1016/B978-0-12-397927-8.00011-7.,335-359.
75. Spangler B., Kappelmann M., Schittek B., Meierjohann S., Vardimon L., Bosserhoff A.K., Kuphal S. ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma. Int. J. Cancer. 2012, 130:2801-2811.
76. Spangler B., Vardimon L., Bosserhoff A.K., Kuphal S. Post-transcriptional regulation controlled by E-cadherin is important for c-Jun activity in melanoma. Pigment Cell Melanoma Res. 2011, 24:148-164.
77. Toft D.J., Rosenberg S.B., Bergers G., Volpert O., Linzer D.I. Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13055-13059.
78. Tsao H., Zhang X., Benoit E., Haluska F.G. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines. Oncogene 1998, 16:3397-3402.
79. van Dam H., Castellazzi M. Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene 2001, 20:2453-2464.
80. Vasudevan S. Functional validation of microRNA-target RNA interactions. Methods 2012, 58:126-134.
81. Vidwans S.J., Flaherty K.T., Fisher D.E., Tenenbaum J.M., Travers M.D., Shrager J. A melanoma molecular disease model. PLoS ONE 2011, 6. e18257.
82. Villanueva J., Vultur A., Herlyn M. Resistance to BRAF inhibitors: unraveling mechanisms and future treatment options. Cancer Res. 2011, 71:7137-7140.
83. Vogt P.K. The oncoprotein. Oncogene 2001, 20:2365-2377.
84. Vogt P.K., Bos T.J., Doolittle R.F. Homology between the DNA-binding domain of the GCN4 regulatory protein of yeast and the carboxyl-terminal region of a protein coded for by the oncogene jun. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:3316-3319.
85. Wang T., Li Q.H., Hao G.P., Zhai J. Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo. Asian Pac. J. Cancer Prev. 2010, 11:193-200.
86. Wei W., Jin J., Schlisio S., Harper J.W., Kaelin W.G. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 2005, 8:25-33.
87. Weiss C., Bohmann D. Deregulated repression of c-Jun provides a potential link to its role in tumorigenesis. Cell Cycle 2004, 3:111-113.
88. Weston C.R., Davis R.J. The JNK signal transduction pathway. Curr. Opin. Cell. Biol. 2007, 19:142-149.
89. Young M.R., Li J.J., Rincon M., Flavell R.A., Sathyanarayana B.K., Hunziker R., Colburn N. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:9827-9832.
90. Zenz R., Scheuch H., Martin P., Frank C., Eferl R., Kenner L., Sibilia M., Wagner E.F. c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. Dev. Cell 2003, 4:879-889.
91. Zhang D., Suganuma T., Workman J.L. Acetylation regulates Jun protein turnover in Drosophila. Biochim. Biophys. Acta 2013, 10.
92. Zhang G., Dass C.R., Sumithran E., Di Girolamo N., Sun L.Q., Khachigian L.M. Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents. J. Natl. Cancer Inst. 2004, 96:683-696.